Literature DB >> 33670563

Epigenetics and Communication Mechanisms in Microglia Activation with a View on Technological Approaches.

Sabrina Petralla1, Francesca De Chirico1, Andrea Miti1, Ottavia Tartagni1, Francesca Massenzio1, Eleonora Poeta1, Marco Virgili1, Giampaolo Zuccheri1,2,3, Barbara Monti1,2.   

Abstract

Microglial cells, the immune cells of the central nervous system (CNS), play a crucial role for the proper brain development and function and in CNS homeostasis. While in physiological conditions, microglia continuously check the state of brain parenchyma, in pathological conditions, microglia can show different activated phenotypes: In the early phases, microglia acquire the M2 phenotype, increasing phagocytosis and releasing neurotrophic and neuroprotective factors. In advanced phases, they acquire the M1 phenotype, becoming neurotoxic and contributing to neurodegeneration. Underlying this phenotypic change, there is a switch in the expression of specific microglial genes, in turn modulated by epigenetic changes, such as DNA methylation, histones post-translational modifications and activity of miRNAs. New roles are attributed to microglial cells, including specific communication with neurons, both through direct cell-cell contact and by release of many different molecules, either directly or indirectly, through extracellular vesicles. In this review, recent findings on the bidirectional interaction between neurons and microglia, in both physiological and pathological conditions, are highlighted, with a focus on the complex field of microglia immunomodulation through epigenetic mechanisms and/or released factors. In addition, advanced technologies used to study these mechanisms, such as microfluidic, 3D culture and in vivo imaging, are presented.

Entities:  

Keywords:  epigenetics; exosomes; miRNAs; microfluidics; neuron–microglia crosstalk

Mesh:

Substances:

Year:  2021        PMID: 33670563      PMCID: PMC7923060          DOI: 10.3390/biom11020306

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  207 in total

Review 1.  In vivo imaging of the diseased nervous system.

Authors:  Thomas Misgeld; Martin Kerschensteiner
Journal:  Nat Rev Neurosci       Date:  2006-06       Impact factor: 34.870

Review 2.  Functions and mechanisms of retrograde neurotrophin signalling.

Authors:  Larry S Zweifel; Rejji Kuruvilla; David D Ginty
Journal:  Nat Rev Neurosci       Date:  2005-08       Impact factor: 34.870

Review 3.  H3K27 demethylases, at long last.

Authors:  Tomek Swigut; Joanna Wysocka
Journal:  Cell       Date:  2007-10-05       Impact factor: 41.582

4.  Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors.

Authors:  Ian F Harrison; William R Crum; Anthony C Vernon; David T Dexter
Journal:  Br J Pharmacol       Date:  2015-07-08       Impact factor: 8.739

5.  CCL11 enhances excitotoxic neuronal death by producing reactive oxygen species in microglia.

Authors:  Bijay Parajuli; Hiroshi Horiuchi; Tetsuya Mizuno; Hideyuki Takeuchi; Akio Suzumura
Journal:  Glia       Date:  2015-07-17       Impact factor: 7.452

Review 6.  Cell-to-cell Communication by Extracellular Vesicles: Focus on Microglia.

Authors:  Rosa C Paolicelli; Giorgio Bergamini; Lawrence Rajendran
Journal:  Neuroscience       Date:  2018-04-13       Impact factor: 3.590

7.  Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma.

Authors:  L Lisi; G M P Ciotti; D Braun; S Kalinin; D Currò; C Dello Russo; A Coli; A Mangiola; C Anile; D L Feinstein; P Navarra
Journal:  Neurosci Lett       Date:  2017-03-02       Impact factor: 3.046

8.  Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein.

Authors:  Barbara Monti; Valentina Gatta; Francesca Piretti; Simonetta S Raffaelli; Marco Virgili; Antonio Contestabile
Journal:  Neurotox Res       Date:  2009-07-21       Impact factor: 3.911

9.  Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease.

Authors:  Kirupa Sathasivam; Andreas Neueder; Theresa A Gipson; Christian Landles; Agnesska C Benjamin; Marie K Bondulich; Donna L Smith; Richard L M Faull; Raymund A C Roos; David Howland; Peter J Detloff; David E Housman; Gillian P Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

Review 10.  Exosomes: biogenesis, biologic function and clinical potential.

Authors:  Yuan Zhang; Yunfeng Liu; Haiying Liu; Wai Ho Tang
Journal:  Cell Biosci       Date:  2019-02-15       Impact factor: 7.133

View more
  2 in total

1.  Platinum nanoparticles Protect Against Lipopolysaccharide-Induced Inflammation in Microglial BV-2 Cells via Decreased Oxidative Damage and Increased Phagocytosis.

Authors:  Zubeyir Elmazoglu; Handan Kayhan; Abel Santamaría; Edgar Rangel-López; Pelin Kelicen Uğur; Aslı Ceylan; Michael Aschner; Çimen Karasu
Journal:  Neurochem Res       Date:  2021-08-25       Impact factor: 3.996

2.  The Anti-Inflammatory Effect of Preventive Intervention with Ketogenic Diet Mediated by the Histone Acetylation of mGluR5 Promotor Region in Rat Parkinson's Disease Model: A Dual-Tracer PET Study.

Authors:  Yuankai Zhu; Xiangyu Tang; Zhaoting Cheng; Qingjian Dong; Ge Ruan
Journal:  Parkinsons Dis       Date:  2022-09-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.